Concert Pharmaceuticals, Inc.

CIK 1367920 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Concert Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Mar 16, 202315-12G0000950103-23-004201
Mar 13, 2023EFFECT9999999995-23-000566
Mar 13, 2023EFFECT9999999995-23-000557
Mar 13, 2023EFFECT9999999995-23-000559
Mar 13, 2023EFFECT9999999995-23-000562
Mar 6, 20238-K0001193125-23-060815
Mar 6, 202325-NSE0001354457-23-000156
Mar 6, 2023S-8 POS0001193125-23-061029
Mar 6, 2023S-8 POS0001193125-23-060989
Mar 6, 202340001209191-23-016163
Mar 6, 202340001209191-23-016167
Mar 6, 2023POS AM0001193125-23-060959
Mar 6, 2023S-8 POS0001193125-23-060977
Mar 6, 202340001209191-23-016165
Mar 6, 2023POS AM0001193125-23-060953
Mar 6, 202340001209191-23-016170
Mar 6, 2023S-8 POS0001193125-23-060998
Mar 6, 202340001209191-23-016168
Mar 6, 2023S-8 POS0001193125-23-060983
Mar 6, 202340001209191-23-016162
Mar 6, 202340001209191-23-016169
Mar 6, 202340001209191-23-016160
Mar 6, 2023S-8 POS0001193125-23-061014
Mar 6, 2023SC TO-T/A0001193125-23-060807
Mar 6, 202340001209191-23-016166